Skip to menu Skip to content Skip to footer
Dr Kim Bridle
Dr

Kim Bridle

Email: 
Phone: 
+61 7 334 60698

Overview

Background

Dr Kim Bridle is currently Senior Research Officer within the Greenslopes Clinical Unit, Faculty of Medicine. Her current research focuses on liver disease treatment and pathogenesis with a focus on hepatic fibrosis, metabolic fatty liver disease and liver cancer. Dr Bridle has made important contributions to the understanding of diseases associated with altered iron metabolism and mechanisms of hepatic fibrosis.

Dr Bridle currently serves on the Research and Grants Committee of the Gastroenterological Society of Australia and is a member of the Ramsay Health Care Human Research Ethics Committee. Dr Bridle is a Section Editor for the journal, BioMed Research International.

Availability

Dr Kim Bridle is:
Available for supervision

Fields of research

Qualifications

  • Bachelor of Science, The University of Queensland
  • Doctor of Philosophy, The University of Queensland

Works

Search Professor Kim Bridle’s works on UQ eSpace

141 works between 1995 and 2025

141 - 141 of 141 works

1995

Journal Article

Effect of Extracellular-Matrix Proteins On Vascular Smooth-Muscle Cell Phenotype

Hayward, I.P., Bridle, K.R., Campbell, G.R., Underwood, P.A. and Campbell, J.H. (1995). Effect of Extracellular-Matrix Proteins On Vascular Smooth-Muscle Cell Phenotype. Cell Biology International, 19 (9), 727-734. doi: 10.1006/cbir.1995.1123

Effect of Extracellular-Matrix Proteins On Vascular Smooth-Muscle Cell Phenotype

Funding

Current funding

  • 2014 - 2025
    Liver Disease Research
    Gallipoli Medical Research Foundation
    Open grant

Past funding

  • 2014 - 2019
    Immunotherapeutic Approaches for Hepatocellular Carcinoma
    Gallipoli Medical Research Foundation
    Open grant
  • 2013
    Targeting Pathophysiology & therapy of liver fibrosis
    Gallipoli Research Foundation
    Open grant
  • 2011 - 2013
    Targeting the Pathophysiology and Therapy of Liver Fibrosis
    NHMRC Project Grant
    Open grant
  • 2008 - 2009
    Reginald Ferguson Fellowship - Rapamycin as an Antifibrotic Agent in Cholestatic Liver Disease
    Ferguson Foundation (Reginald Ferguson)
    Open grant
  • 2007 - 2010
    The pathogenesis of co-toxic liver disease
    Queensland Health Smart Health Research Grant
    Open grant
  • 2006 - 2008
    Reginald Ferguson Research Fellowship - Primary Sclerosing Cholangitis - A Life Threatening Complication of Inflammatory Bowel Disease: Investigations to Attenuate Disease Progression
    Ferguson Foundation (Reginald Ferguson)
    Open grant
  • 2006 - 2007
    The use of rapamycin to slow scarring of the liver
    Royal Children's Hospital Foundation
    Open grant
  • 2006 - 2009
    Immunosuppressant-Mediated Changes in Extracellular Matrix Balance in Animal Models of Liver Disease
    Princess Alexandra Hospital R&D Foundation
    Open grant
  • 2005 - 2007
    Does immunosuppression affect the post-transplantation hepatic fibrogenic response?
    NHMRC Project Grant
    Open grant
  • 2005
    The Influence of Immunosuppression on the Hepatic Stellate Cell Fibrogenic Response
    UQ Early Career Researcher
    Open grant
  • 2004 - 2007
    Pathogenic mechanisms underlying iron co-toxicity in chronic liver disease
    Gastroenterological Society of Australia
    Open grant

Supervision

Availability

Dr Kim Bridle is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Available projects

  • Novel Therapies for Co-toxic Liver Disease

    This project will examine the pathogenesis of co-toxic liver disease and will study the restoration of iron homeostasis as a potential therapeutic application in liver diseases associated with altered iron metabolism.

Supervision history

Current supervision

Completed supervision

Media

Enquiries

For media enquiries about Dr Kim Bridle's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au